Staphylococcus aureus causes a variety of diseases in humans and animals and produces a large number of secreted proteins which contribute to infection (4, 7) . Recent comparative genomic studies have revealed a high level of interstrain variation in genome content, particularly at regions containing genes encoding virulence factors or antibiotic resistance mechanisms (2, 5, 6) . For example, a recent DNA microarray study examining genomic variation in S. aureus identified 18 large chromosomal regions of difference among 36 strains isolated from different infection types in humans, cows, and sheep (6) . Among the 18 large chromosomal regions identified, one (RD13) varied in size from 12 to 17 kb and was predicted to contain considerable variation in gene content (Fig. 1) . RD13 corresponds to the exotoxin gene-containing regions of genomic islands SaPIn2 and SaPIm2, identified in S. aureus strains N315 and Mu50, respectively (10) . RD13 has open reading frames encoding hypothetical proteins, a transposase, a restriction-modification system, and at least seven staphylococcal exotoxin-like (SET) proteins, depending on the strain (Fig. 1) . Analysis of the inferred amino acid sequences indicates that SET proteins contain internal regions of homology with superantigens made by S. aureus and group A Streptococcus. Superantigens produced by S. aureus and group A Streptococcus are thought to modulate the host immune response during infection by binding and activating T-cell subsets expressing specific V␤ chains of the T-cell receptor (4, 11, 14) . However, a very recent study reported that a purified recombinant SET variant did not have the classical characteristics of superantigens, such as mitogenicity, pyrogenicity, or the enhancement of endotoxic shock (1) . A representative SET (SET3) has the classical threedimensional structure which is characteristic of superantigens, but there are some notable differences perhaps reflecting an alternative function. In particular, SET3 has a large, positively charged, saddle-shaped surface that has the potential to act as a binding surface for negatively charged molecules such as DNA (1) . However, the function of this family of proteins has yet to be established.
The precise molecular processes leading to genome diversification in pathogenic bacteria remain unclear. Many of the variable chromosomal regions identified in the genome of S. aureus are related to insertion elements, transposons, phage, and pathogenicity islands and are found in only a portion of strains examined, indicating the role of horizontal gene transfer in S. aureus evolution. However, a large region (RD13) of the chromosome with extensive variation in virulence gene content was identified in all strains examined by microarray analysis. The unusual variation in nucleotide and gene content of RD13 raised important questions regarding the processes that have contributed to the genetic diversity of RD13 and to the evolution of the S. aureus genome in general. In the present study, comparative sequencing, PCR-restriction fragment length polymorphism (RFLP) analysis, gene and protein expression assays, and evolutionary genetic analyses were used to investigate the molecular evolution and genetic diversity of RD13 in strains of S. aureus isolated from human and animal infections. A model for the evolutionary history of RD13 among pathogenic clones is proposed.
MATERIALS AND METHODS
S. aureus strains. Strains were selected to represent the most abundant clonal lineages identified in a multilocus enzyme electrophoresis (MLEE) population genetic study of over 2,000 S. aureus isolates and were of broad geographic and disease origin (Table 1) (12) .
RD13 PCR-RFLP analysis. PCR primers (forward primer, 5Ј-CAA AGC TAA ACA AGA CGG CTT TGA TG-3Ј; reverse primer, 5Ј-TCC GCG CCA ATC TTC TGG AAC-3Ј) specific for conserved regions flanking RD13 were used to amplify the intervening sequence with the Advantage genomic PCR kit (Clontech, Palo Alto, Calif.) according to the manufacturer's instructions. The PCR products were digested with restriction endonuclease HinP1I at 37°C for 2 h, and the DNA restriction fragments were resolved by electrophoresis in a 1.2% agarose gel.
Analysis of size variation in Vr in RD13. The size of the RD13 variable region (Vr) in each strain was inferred on the basis of amplification by PCR with primers (forward primer, 5Ј-ATA GAA CTC GCC TGC TTT TTT ACC-3Ј; reverse primer, 5Ј-CCA AAG CCT TTA GGT TCA TCA TAC A-3Ј) specific for conserved flanking regions (the mod and orf3 genes, respectively) ( Fig. 1) DNA sequence analysis. Sequence data obtained from both DNA strands with an Applied Biosystems model 3700 automated sequencer were analyzed by DNASTAR (Madison, Wis.). Multiple-sequence alignment of the inferred amino acid sequences was performed with Clustal W version 1.8 (18) . Statistics of nucleotide and amino acid content were determined with MEGA version 2.1 (9) .
Population and molecular evolutionary genetic analyses. The Nei-Gojobori method (13) was used to calculate the proportion of synonymous sites in nucleotide sequence data. Phylogenies were constructed with the neighbor-joining algorithm by using MEGA version 2.1 (9) . A concatenated sequence consisting of orf2, set1, res, mod, set2, set3, set9, set10, and set11 was used for the analysis of the conserved architecture of RD13. Due to strain-to-strain variation in the content of certain set genes, set4, set5, set6, set7, and set8 were studied independently. To examine variation in the patterns of nucleotide substitution, the proportion of synonymous (p S ) and the proportion of nonsynonymous (p N ) nucleotide substitutions were calculated by sliding-window analysis of 30 codons along each gene with the program PSWIN (15) (PSWIN is available from S. D. Reid [sreid@niaid.nih.gov]). Estimates of the sampling variance of these statistics were made by Monte Carlo simulation or by bootstrapping.
To identify the putative end points of past recombination events, a computer program (MAXCHI) that implements the maximum chi-square method was used (16) . Happlot analysis was used to diagram the locations of polymorphic sites.
Real-time reverse transcriptase PCR (TaqMan assays). PCR primers and probes were designed with the software package Primer Express (Perkin-Elmer) on the basis of the genomic DNA sequence available for S. aureus strain COL (http://www.tigr.org) and purchased from PE Applied Biosytems. Total RNA was isolated from bacteria cultured for 3 h (mid-exponential phase) or 12 h (stationary phase), and reverse transcription and PCRs were performed as described previously (3) . To confirm that the era gene encoding the GTP-binding protein Era was constitutively expressed and suitable for use as an internal control, the amount of era mRNA was measured in three separate reverse transcriptase PCR experiments with two independent RNA samples isolated from mid-exponential and stationary-phase cultures of strain COL. The results confirmed that era is expressed at similar levels (0.9 to 1.3 relative expression levels) in both phases of the growth cycle (data not shown). set gene cloning and production of recombinant SET proteins. The primers, vectors, and restriction enzymes used for PCR amplification and cloning of the set genes of S. aureus strains COL and 8325 are listed in Table 2 . The primers were designed on the basis of genome sequences available for S. aureus strains COL (http://www.tigr.org) and 8325 (http://www.genome.ou.edu), and restriction enzyme sites for cloning were included in each primer. PCR products were amplified with genomic DNA isolated from strain COL or strain 8325, digested with the appropriate restriction enzymes, and cloned into vector pET21b or pET15. The cloned genes were sequenced to ensure that spurious mutations had not been introduced, and the plasmids were moved into Escherichia coli BL21 for expression of recombinant proteins.
To assess the production of recombinant proteins, BL21 cells with recombinant plasmids were grown at 37°C for 10 h in 3 ml of Luria-Bertani broth supplemented with 100 mg of ampicillin per liter. Cells were pelleted by centrifugation and suspended in 1ϫ sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer at a ratio of 100 l of buffer per 1 unit of optical density 600 nm per ml. The samples were boiled for 10 min and analyzed by SDS-PAGE.
Purification of recombinant SET protein.
To purify recombinant SET6 protein, BL21 cells with recombinant plasmid were grown overnight at 37°C in Luria-Bertani broth. The culture was treated with 4 volumes of absolute ethanol for 48 h, and the precipitated proteins were collected by centrifugation (500 ϫ g, 10 min). Five liters of total culture volume was combined in a single culture toxin preparation. The precipitate was air dried after centrifugation and resuspended in 100 to 150 ml of pyrogen-free water. The resuspended precipitate was centrifuged at 10,000 ϫ g for 30 min; the concentrated supernatant was removed, placed in dialysis tubing with a 12,000-to 14,000-molecular-weight cutoff (Spectrum Laboratories, Inc., Miami, Fla.), and dialyzed overnight against 4 liters of distilled water. The dialyzed supernatant was subjected to preparative isoelectric focusing. Successive gradients of pH 3.5 to 10 and pH 6 to 8 were used to isolate highly purified recombinant SET6 protein. Final purification of proteins was accomplished with a gel filtration column (Bio-Rad Laboratories, Hercules, Calif.) containing Sephadex G-75 (Sigma, St. Louis, Mo.). Purity was verified by SDS-PAGE in which 10 g gave a homogenous band of the appropriate molecular weight. The concentration of the purified protein was assessed with the Bradford protein assay (Bio-Rad) (2a), and the protein was lyophilized and stored until used in biological and biochemical assays.
Assay for superantigen activity. Rabbit splenocytes or human peripheral blood mononuclear cells (PBMCs) were seeded into the wells of a 96-well microtiter plate at a concentration of 2 ϫ 10 5 cells per well. Serial 10-fold dilutions of SET or toxic shock syndrome toxin 1 (TSST-1; positive control) were added to each well in quadruplicate, starting with 1 g/well and with dilution to 10 Ϫ8 g/well.
The assay results for these dilutions were compared to those for cells incubated in the presence of phosphate-buffered saline alone. The splenocytes were grown at 37°C for 3 days and pulsed with 1 Ci of [ 3 H]thymidine overnight. The cells were harvested the next day, and cell proliferation (incorporation of 3 H into DNA) was measured with a scintillation counter (Beckman Instruments, Fullerton, Calif.).
Pyrogenicity and endotoxin enhancement. American Dutch belted rabbits were injected intravenously with recombinant SET proteins at a maximal dose of 10 g/kg of body weight per ml. The temperature of each rabbit (n ϭ 3) was measured with a rectal thermometer at 0 and 4 h postinjection. After 4 h, each rabbit was injected intravenously with 10 g of lipopolysaccharide from Salmonella enterica serovar Typhimurium (1/50 of the 50% lethal dose of endotoxin alone). The lethality of this toxin regimen was assessed over a 48-h period.
Western immunoblot analysis. Proteins separated by SDS-PAGE were transferred to nitrocellulose membranes (Immobilon-NC; Millipore Corporation) with Towbin transfer buffer with a Trans-Blot SD semidry transfer cell (Bio-Rad Laboratories) at 15 V for 40 min. The membrane was incubated with 10 ml of block solution (5% powdered milk in 150 mM NaCl and 100 mM Tris-HCl, pH 7.4) for 1 h, incubated for 1 h with a 1:500 dilution of human patient serum in block solution, rinsed twice, and washed three times for 15 min each time with 0.1% Tween 20 in phosphate-buffered saline. The membrane was incubated with goat anti-human immunoglobulin G horseradish peroxidase-conjugated secondary antibody (Sigma) for 1 h and rinsed and washed as described above. Immunoreactivity was visualized by enhanced chemiluminescence. The human serum samples were obtained during a countrywide study of invasive episodes of S. aureus infection in Finland in 1999 and 2000. Patients had infections with or without deep infection foci, including abscesses, cellulitis, pneumonia, and purulent arthritis. Sera were obtained 2 to 7 days (i.e., the acute phase) and 20 to 30 days (i.e., the convalescent phase) after the first positive blood culture. Control serum samples were obtained from four female and four male healthy volunteers, including Caucasian, African-American, Hispanic, and Asian individuals (n ϭ 2 each).
Nomenclature of the SET family of proteins. To date in the literature, there has been no coherent system regarding the numbering of the members of the SET protein family. All S. aureus strains examined to date, including the genetically divergent strains in the present study, contained between 7 and 11 different set genes in RD13. Comparison of RD13 chromosomal regions from different strains indicates that the overall set gene order of RD13 is conserved and that set genes at the same position in RD13 in different strains are allelic variants of each other (85 to 100% homology). Accordingly, we propose that the set gene family of RD13 should be named set1 to set11 in consecutive order based on strains with a full complement of set genes in RD13 (Fig. 1) . To differentiate between allelic variants of set genes found in different strains, the gene number should be prefixed by the strain name, e.g., COLset1. 
RESULTS
Characterization of structural variation in RD13. Analysis of the RD13 region in seven sequenced S. aureus strains, COL (http://www.tigr.org), 8325 (http://www.genome.ou.edu), methicillin-resistant S. aureus (MRSA) 252 (Sanger MRSA) and methicillin-susceptible S. aureus (MSSA) 476 (Sanger MSSA) (http://www.sanger.ac.uk), N315 and MW2 (http://www.bio.nite.go.jp), and Mu50 (GenBank accession no. NC_002758), revealed that the gene order at this chromosomal site is well conserved in all isolates. Allelic variants of six of the seven set genes contained in RD13 in strain COL were present in all seven sequenced strains (Fig. 1) . A summary of the size and degree of polymorphism among set genes in the seven sequenced strains is represented in Table 3 . Analysis of the degree of polymorphism among predicted SET proteins from a single strain, COL, revealed 22.8 to 64.5% identity, and pairwise analysis of allelic variation among set genes common to the seven sequenced strains revealed between 85 and 100% identity at the nucleotide level. In addition, between 6 and 10 set variant genes were present in a central Vr depending on the strain (Fig. 1) .
In a previous study, Williams et al. (19) sequenced a 5.2-kb DNA segment containing set genes from a human S. aureus strain, NCTC6571 (Fig. 1) . This fragment is identical to a region internal to RD13 in the sequenced MRSA strain 252 and includes set2, set3, set5, set7, part of set8, and part of the restriction-modification subunit gene. The prototype set1 gene which was cloned and overexpressed in E. coli in the Williams et al. study is an allele of set5 of the set gene family (Fig. 1) .
PCR-RFLP analysis of RD13.
To analyze structural variation in chromosomal region RD13 among S. aureus strains representing the breadth of diversity within the species, a PCR-RFLP method was developed. We analyzed 44 strains that represent each of the major clonal complexes identified in an MLEE population genetics study of more than 2,000 isolates from diverse infection types, localities, and host species (12) ( Table 1) . Twenty-seven distinct PCR-RFLP types were identified ( Fig. 2 ; Table 1 ), indicating that substantial variation exists at this chromosomal region in natural populations. Each strain had 7 to 12 restriction fragments in total, which were between 0.5 and 4.5 kb in length, and resulted in restriction profiles that were readily distinguishable (Fig. 2) . Most of the 27 PCR-RFLP types comprised relatively few isolates (range, (8) . (An index of 1.0 would indicate that a typing method was able to distinguish each member of a strain population from all other members, whereas an index of 0.0 would indicate that all members of the population were of an identical type.) Taken together, these data clearly indicate a high degree of genetic diversity at this chromosomal region. We also analyzed the RD13 PCR-RFLP patterns of 19 S. aureus isolates recovered from patients with invasive infections whose sera were used in Western immunoblot analysis (see below). Among these 19 organisms, 7 had RD13 PCR-RFLP profiles which were identical to type 13 or differed by the presence of one or two restriction sites (types 33 and 34). Two isolates were PCR-RFLP type 16; there were single isolates of type 2, type 6, type 8, and type 15; and five isolates had unique RD13 PCR-RFLP profiles (types 27 to 31). A PCR product could not be generated for one isolate.
PCR analysis of the Vr of RD13. PCR amplification was used to determine the size of the Vr among the 63 strains used in this study (Fig. 2) . The primers used were specific for nucleotides located approximately 700 and 800 bp upstream and downstream, respectively, of the Vr. The estimated size of the Vr was calculated by subtracting 1.5 kb from the size of the PCR product. Three strains had Vrs of 7 kb, 5 strains had Vrs of 8 kb, 19 strains had Vrs of 9 kb, 17 strains had Vrs of 10 kb, and 19 strains had Vrs of 11 kb (Table 1) . Based on the set gene content of the Vrs in the six sequenced strains, these results are consistent with the presence of 6, 7, 8, 9, or 10 set genes in this chromosomal region in S. aureus strains.
Phylogenetic analysis of RD13. Phylogenetic analysis was used to reconstruct the evolutionary history of the RD13 locus and to determine the extent that recombination contributed to the divergence of the region (Fig. 3) . To add to the publicly available genome sequences of S. aureus strains 8325, Sanger MSSA, Sanger MRSA, N315, Mu50, and COL, DNA sequencing of variably present set genes (Vr) of 12 selected strains was carried out. Strains were selected based on Vr size variation and clonal diversity (determined by MLEE) (strains 1006, 1260, 141, 143, 145, 147, 232, 240, 3400, 3402, 537, and 554). The set4, set5, set6, set7, and set8 genes were found to be variably absent in the strains examined. A phylogenetic tree was constructed from the concatenated nucleotide sequences of orf2, set1, res, mod, set2, set3, set9, set10, and set11 (i.e., genes in RD13 that are common to all strains) from the previously sequenced strains 8325, Sanger MSSA, Sanger MRSA, N315, Mu50, and COL to represent the conserved architecture of the RD13 locus. The topology of this tree was compared to the topologies of the individual gene trees of set4 ( . Extensive recombination would result in set genes composed of segments of DNA with different evolutionary histories and conflicting phylogenetic topologies. However, we found that the topology representing the conserved regions of RD13 and each of the individual topologies constructed for genes set4 to set7 were consistent, suggesting that recombination had not occurred at a sufficiently high frequency to distort the phylogenetic signal.
The analysis suggested two models for the evolution of the RD13 locus (Fig. 3) . One model requires a common ancestor which has only set5 and set7. The present-day complement of set genes in each lineage would have arisen through multiple acquisition and deletion events. In this case, one would expect less variation in the form of synonymous (silent) nucleotide substitutions in the recently acquired set genes. However, our analysis indicated that the proportions of polymorphic synonymous sites in set4 to set7 are very similar, a result inconsistent with this model. Alternatively, the ancestral state could be represented by a complete complement of set genes in the Vr. In this model, extant states are explained by the loss of set genes in parallel in separate lineages of pathogenic S. aureus (Fig. 3) . The occurrence of similar proportions of synonymous sites strongly supports this idea. Taken together, these analyses suggest that the evolution of the RD13 locus is explained by a model in which the loss of set genes has occurred several times independently in separate lineages of pathogenic S. aureus (Fig. 3) . While the extent of horizontal gene transfer has been insufficient to mask the phylogenetic signal present, recombination may have contributed to chromosomal diversification at the RD13 locus. To investigate this possibility, the maximum 2 method was used to identify putative end points of past recombination. Multiple end points flanking small regions of the sequence throughout the RD13 locus were identified (data not shown). The largest of these regions was identified in the res gene based on a comparison of six strains (Fig. 3) . Restricted allelic variation within the recombined segments of the res gene suggests that recombination has occurred recently.
Analysis of the level of selective constraint acting on set genes. Considering the high level of predicted homology among SET proteins produced by a single strain, it is conceivable that SETs may have some redundancy of function. Accordingly, we examined the possibility that one or more set genes may have become silent. Silent genes are free to accumulate synonymous (silent) mutations and corresponding amino acid replacements, as selective constraint is no longer acting to maintain protein function by limiting deleterious amino acid replacements. To determine if the level of selective constraint varies across RD13, we calculated p N and p S for subsets of 30 codons in a sliding window for the length of each set gene (Fig. 4) . The difference, p N Ϫ p S , is a measure of the degree of selective constraint. The more negative the value, the MOLECULAR EVOLUTION OF AN S. AUREUS CHROMOSOME REGIONless the contribution of amino acid replacements and the greater the contribution of synonymous nucleotide substitutions. A difference of zero indicates selectively neutral variation, where the per-site rates of synonymous and nonsynonymous substitutions are equal. A positive difference (i.e., amino acid replacements exceeding silent substitutions) suggests the action of diversifying (positive) selection. Overall, the p N Ϫ p S difference is consistently negative for each of the set genes, a value indicative of purifying selection (Fig. 4) . The set9 gene did possess a single region 53 codons in length, stretching from position 17 to position 69, in which the value for p N Ϫ p S was Ն0. In this region, the rate of substitution per 100 sites is expressed by the equations d N ϭ 9.3 Ϯ 2.1 and d S ϭ 10.1 Ϯ 3.8.
The results suggest that if any of the set genes were silenced, it was a very recent event given that the number of corresponding amino acid replacements has not had sufficient time to accumulate substantially. Expression of genes located in RD13 in S. aureus strain COL. To test the hypothesis that the genes in RD13 are transcribed, TaqMan assays were used to determine relative genespecific mRNA levels present in mid-exponential and stationary-phase S. aureus cells (Fig. 5) by using the oligonucleotides listed in Table 4 . No transcript was detected in either exponential-or stationary-phase cells for set1, hypothetical orf5, and the putative transposase (tra) genes, a result indicating that these three genes are not transcribed in vitro at these time points under the conditions studied. In contrast, all other genes examined were either constitutively expressed during the growth cycle (res, mod, and set2) or were up-regulated in the stationary phase of growth (orf1 to orf3, orf5, set3, set8, set9, set10, and set11) (the cutoff was a 1.5-fold increase in the normalized transcript level).
Western blot analysis of recombinant SET proteins with sera from patients with invasive S. aureus infections. To determine if SET proteins are expressed during the course of human infection and stimulate a humoral immune response, Western immunoblot analysis of recombinant SET proteins was carried out with paired acute-and convalescent-phase serum samples from 19 patients with S. aureus bacteremia. Of the panel of 11 recombinant SET proteins, 6 were immunoreactive with sera obtained from at least one patient, indicating expression of these proteins during human infection (Table 5) . SET2, SET4, SET5, SET8, SET9, and SET10 were reactive with sera from 13, 1, 4, 12, 18, and 3 of the 19 patients examined, respectively. SET1, SET3, SET6, SET7, and SET11 were not reactive with any of the 19 patient sera. Of the 11 recombinant proteins, only SET9 was reactive with any of the eight control sera tested (n ϭ 2) (data not shown). A representative Western blot is shown in Fig. 6 . Biological activity of SET6. We next assessed whether a representative protein (SET10) encoded by a gene in the RD13 locus (Fig. 1) had superantigenic activity. In a standard assay, SET6 was unable to stimulate rabbit splenocyte or human PBMC proliferation whereas TSST-1 (positive control protein) stimulated proliferation of both rabbit splenocytes and human PBMCs (data not shown).
The pyrogenic activity of purified SET6 and its ability to enhance endotoxic shock also were examined. SET10 did not cause fever in rabbits at a dose of 10 g/kg and did not enhance the lethality of endotoxin administered to rabbits. TSST-1 administered at the same dose was pyrogenic and enhanced the lethality of endotoxin (data not shown).
DISCUSSION
Several comparative genomic studies have highlighted the extensive variation that exists within natural populations of some pathogenic bacteria, but the molecular mechanisms of genome diversification are still unclear. We identified extensive variation in RD13, a region of the chromosome that is common to all strains of S. aureus examined. This variation included the sequence divergence of genes common to all strains and differences in gene content, as indicated by RD13 PCR-RFLP, size, and DNA sequence analyses. The seven S. aureus strains whose genomes have been sequenced had an RD13 central Vr of 7, 9, 10, or 11 kb corresponding to 6, 8, 9, or 10 set genes, respectively (Fig. 1) . Most of the 63 strains examined by PCR had an RD13 with one of these Vr size variants. However, four strains had a Vr of 8 kb, consistent with the presence of seven set genes in the Vrs in these strains. This inference was confirmed by DNA sequencing. The presence of a large and variable number of set genes and the observed sequence divergence in the RD13 locus suggested that molecular evolutionary genetic analysis would provide insight into the processes shaping variation in this region. To investigate the evolution of RD13, we adopted a strategy in which separate phylogenies were constructed to represent the conserved architecture of the locus and the variable set genes. The analysis suggested two models of evolution for RD13 (Fig.  3) . One model requires a common ancestor which possesses only set5 and set7. In this situation, multiple gene acquisition and gene loss events would have led to the present-day complement of set genes in each lineage. However, based on a similar proportion of synonymous (silent) nucleotide substitutions in all set genes in the Vr, the most likely scenario is that an ancestral strain with a full complement of set genes in the Vr underwent multiple independent losses of set genes in parallel in distinct lineages. In each case, the set gene losses were confined to the set4 to set8 genes. It is unlikely that there is a selective disadvantage to possessing one or more of the set4 to set8 genes, as two strains (8325 and MSSA) have a copy of each gene in their extant states. In addition, analysis of nucleotide substitution in the set4 to set8 genes did not reveal a marked decrease in functional constraint that may accompany a deleterious allele.
The presence of RD13 in all strains representing the major clonal lineages within the species and the existence of a GϩC content which is equivalent to that of the S. aureus genome both suggest that RD13 is an ancient feature of the S. aureus chromosome. DNA sequence analysis indicated that horizontal gene transfer and recombination have contributed to the diversification of RD13 in different strains (Fig. 3) . The presence of a transposase gene in this region supports this theory, although this gene was not expressed in strain COL under the conditions studied and has been lost altogether by the recently sequenced strain MW2. The presence of many related but not identical set genes is suggestive of distant gene amplification events followed by sequence divergence which resulted in a common S. aureus ancestor with a full complement of set genes in RD13 (Fig. 3) . Our data show that the restriction-modification system genes in RD13 are expressed in vitro. Interestingly, restrictionmodification system genes are found in another large variable region in the S. aureus chromosome adjacent to a cluster of six genes encoding a family of serine proteases (6) . The significance of their close proximity has yet to be established, but it is possible that restriction-modification systems may have played a role in the evolution or regulation of some paralogous gene families in the S. aureus chromosome.
DNA sequence analysis of the ratio of synonymous nucleotide substitutions in set genes to amino acid substitutions in their products suggested that the functionality of set genes has been maintained by purifying selection (Fig. 4) . Gene expression assays indicated that only one of seven set genes (set1) in strain COL was not expressed in vitro under the conditions tested. The set genes were expressed in a growth-phase-dependent manner (Fig. 5) with the highest transcription levels detected during the stationary phase of growth. In this regard, the set genes are similar to many staphylococcal exotoxin genes associated with virulence which are typically up-regulated postexponentially. Of note, the set genes were expressed concurrently, suggesting that multiple SET proteins may participate in host-pathogen interactions simultaneously. The identification of putative promoters upstream of several set genes (data not shown) suggests that the set genes may be encoded by multiple transcripts. The cotranscription of six set genes also indicates that a mechanism of phase variation mediated by gene cassette switching does not occur at this locus. Considering the evident selective constraint on SET proteins, it is likely that set gene deletions are a relatively rare occurrence. Of note, no RD13 gene deletions were observed during continuous in vitro passage of a clinical strain of S. aureus for a 6-week period, thus indicating the stability of this chromosomal region during growth in vitro (17) .
The evolutionary basis for maintenance of production of many related SET proteins by S. aureus is unclear. However, the data indicate that multiple SET proteins are expressed during human infection and induce a humoral immune response. Although all patient sera examined contained antibodies to one or more recombinant SET proteins from strain COL or 8325, not all SET variants were immunoreactive. The possibility that different strains may produce antigenically distinct SET variants is consistent with the variation in the set gene content and DNA sequence identified in different strains. It is conceivable that SET allelic variation may represent a mechanism of immune avoidance employed by S. aureus which may encounter hosts that have already been exposed to SET proteins during previous staphylococcal infections. Alternatively, the variation in immunoreactivity in human patient sera may be explained by the possibility that some SET proteins did not elicit a strong immune response or are poorly expressed in some strains. The SET protein family may have evolved as a result of the occurrence of host receptors which are polymorphic between individuals, such that the production of many SET proteins may increase the chances of effective interaction with such receptors. However, it is also conceivable that although the SET proteins have high sequence homology and similar predicted structures, each protein has a related but distinct function in host-pathogen interactions.
We examined a SET variant (SET6) for superantigen activity. In spite of the presence of the two superantigen consensus domains, SET6 did not have the classical properties of superantigens such as superantigenicity, pyrogenicity, or enhancement of endotoxic shock (data not shown). This finding is consistent with that of a recent study (1) of a different SET variant (SET3), which indicates that SET proteins may have biological activities that are distinct from those of superantigens. The study by Arcus et al. (1) suggests that SET proteins have some of the characteristics of DNA-binding proteins, and further analysis will help define a clearer role for SET proteins in pathogenesis.
In this study, we explored the molecular evolution of a large chromosomal region common to all strains of S. aureus which encodes a family of proteins putatively involved in pathogenesis. We found extensive genetic diversity and variation in the set gene content at the chromosomal region RD13 within the S. aureus species, and we proposed a likely evolutionary scenario for the locus in contemporary pathogenic S. aureus strains that involves multiple episodes of set gene deletion in different clonal lineages in parallel. We also found that horizontal gene transfer and recombination have contributed to the diversification of this chromosomal locus. Functional constraint is acting to maintain the expression of set genes, and multiple SET proteins are expressed during human infections, suggesting a possible role in host-pathogen interactions. Taken together, these findings represent new insights bearing on the evolution and diversification of the genome of pathogenic S. aureus.
